Johnson & Johnson Climbs After Beating Quarterly Estimates

Now watching

Next video starts in : 7 Play

Johnson & Johnson Climbs After Beating Quarterly Estimates

Johnson & Johnson Climbs After Beating Quarterly Estimates
Replay video
Up next

Volatility to continue into the spring: Koesterich

Unlock your personal NFL Now stream by signing in to NFL.com

Johnson & Johnson Climbs After Beating Quarterly Estimates

by TheStreet.com Videos 0:50 mins

Johnson & Johnson shares are climbing on Tuesday after posting an all-round first-quarter beat. The healthcare giant posted earnings of $1.54 a share -- that was $0.06 higher than analysts expected and nearly 7% higher year over year. The higher profits stemmed from strong sales growth in its prescription drugs segment, which soared 11% over the quarter. As for total revenue, that grew 3.5% year on year to $18.1 billion, around $111 million over analysts' expectations.

View Comments (0)